Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Ceramide Cream in Treating Women With Cutaneous Breast Cancer

ClinicalTrials.gov ID: NCT00008320

Public ClinicalTrials.gov record NCT00008320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 1:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of ceramide cream in treating women who have cutaneous breast cancer.

Study identification

NCT ID
NCT00008320
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
26 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2001 (Type not available)
Primary completion
Apr 2002 (Actual)
Completion
Oct 2009 (Actual)
Last update posted
Dec 6, 2016

2001 – 2009

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206 —
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016 —
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733 —
CCOP - Wichita Wichita Kansas 67214-3882 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131 —
Medcenter One Health System Bismarck North Dakota 58501 —
CCOP - Merit Care Hospital Fargo North Dakota 58122 —
CCOP - Toledo Community Hospital Oncology Program Toledo Ohio 43623-3456 —
Rapid City Regional Hospital Rapid City South Dakota 57709 —
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57105-1080 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00008320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 6, 2016 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00008320 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →